HBIO HARVARD BIOSCIENCE INC

NEUTRAL Impact: 3/10 Insider Cluster (2 insiders)
Horizon days Filed Mar 16, 2026 Processed 2mo ago
Insider cluster: 2 insiders, $74K total
Latest settled — T+20d
HBIO ▼ -2.00% at T+20d
NEUTRAL call ✗ call lost -2.00% · α vs SPY -5.78% · entry $5.01 → $4.91
Next anchor: T+60d due 16h ago
Currently $6.04 · +20.56% from $5.01 entry
Entry anchored
Mar 13, 03:59 PM ET
via Databento tick
T+1d
-2.79%
call -2.79% · α -3.07%
$4.87
settled 3mo ago
T+5d
+6.59%
call +6.59% · α +8.63%
$5.34
settled 3mo ago
T+20d
-2.00%
call -2.00% · α -5.78%
$4.91
settled 8w ago
T+60d
call — · α —
due 16h ago

Price Chart

Loading chart...

Executive Summary

HBIO CEO received a non-cash grant of 75,000 shares, while a director made an open-market purchase of 10,000 shares for $48,700. The CEO's transaction is a routine award with no economic cost; the director's buying adds modest conviction.

Key Financial Metrics

Direction
buying
Total Value
$48.7K
Insiders
2

Actionable Insight

Minor insider buying by a director adds slight positive sentiment, but CEO's grant is routine. Monitor for follow-up purchases or additional insider activity ahead of next earnings.

Key Facts

  • CEO Duke John D was granted 75,000 shares at $0 (non-cash event, no market impact)
  • Director Stephen J. Denelsky purchased 10,000 shares in the open market for $48,700
  • Total open-market buying: $48,700 (0.2% of $24M market cap)
  • No open-market selling or cash-related transactions

Financial Impact

$48,700 in open-market buying (0.2% of market cap), one non-cash grant

insider sentimentshare count (dilution potential)

Risk Factors

  • The CEO share grant may lead to future dilution if not part of a pre-approved plan
  • Small market cap makes HBIO vulnerable to volatility from low-volume trades

Market Snapshot

Exchange
Nasdaq

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (2 trades, 7d window)cluster-HBIO-1774273716700
8 reports for HBIO
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for HBIO — sortable, filterable
Type Now
Jun 2, 2026
7d ago
8-K
NEUTRAL ★ 3/10
$6.50 $6.48▼ −0.31%▼ −0.71%$6.04 (−7.08%)
May 12, 2026
28d ago
8-K
MIXED ★ 5/10
$5.41 $5.57▲ +2.96%▲ +2.38%$6.04 (+11.65%)
May 12, 2026
28d ago
8-K
BEARISH ★ 6/10
$5.41 $5.57▼ −2.96%▼ −2.38%$6.04 (−11.65%)
May 12, 2026
28d ago
Press Release
NEUTRAL ★ 4/10
$5.41 $5.57▲ +2.96%▲ +2.38%$6.04 (+11.65%)
Mar 16, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$5.01 $4.87▼ −2.79%▼ −3.07%$6.04 (+20.56%)
Mar 16, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$5.01 $4.87▼ −2.79%▼ −3.07%$6.04 (+20.56%)
Mar 16, 2026
12w ago
Insider Cluster
BULLISH ★ 6/10
$5.01 $4.87▼ −2.79%▼ −3.07%$6.04 (+20.56%)
Mar 12, 2026
12w ago
8-K / PRESS-RELEASE
MIXED ★ 6/10
$4.90 $4.70▼ −4.08%▼ −3.48%$6.04 (+23.27%)
Showing 8 of 8

US Market Status

Market Closed — Opens Thu (9h 49m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access